Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1.

Source:http://linkedlifedata.com/resource/pubmed/id/16809318

Download in:

View as

General Info

PMID
16809318